Literature DB >> 20177127

The risks and costs of multiple-generic substitution of topiramate.

Nitin K Sethi, Josh Torgovnick, Prahlad K Sethi, Edward Arsura, Pierre Emmanuel Paradis, Mei S Duh, Michael B Durkin, George J Wan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20177127     DOI: 10.1212/WNL.0b013e3181c7770b

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  1 in total

1.  Clinical experience with generic levetiracetam in people with epilepsy.

Authors:  Siresha Chaluvadi; Sharon Chiang; Larry Tran; Corey E Goldsmith; David E Friedman
Journal:  Epilepsia       Date:  2011-03-22       Impact factor: 5.864

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.